BioElectronics Company Update: Sept 30, 2016

  • September 30th, 2016
  • News
  • 1 Comment
  • Adam Staelin

Reflexonic, LLC On September 9, 2016, we signed an Exclusive Licensing and Supply Agreement with Reflexonic, LLC. Reflexonic sells and distributes urological medical devices, products, and related medical products. Reflexonic will assist in the development of urological products for the treatment of overactive bladder, interstitial cystitis and bladder pain syndrome by providing device therapeutic specifications, […]

BioElectronics Company Update: August 22, 2016

  • August 22nd, 2016
  • News
  • 0 Comments
  • Adam Staelin

Pending FDA Market Clearance for Over-the-Counter Sales We had a second status meeting with the FDA on Wednesday, July 20, 2016. Senior Management from the Neurology and Physical Medicine Group, 4 examiners, the Head of the Physical Medicine, and the project statistician were present. The meeting went well and the tenor was very good. Our […]

Your Voice Matters

  • July 26th, 2016
  • News
  • 0 Comments
  • Adam Staelin

How is your chronic pain treated? If you feel your illness is misunderstood and you could use better or less costly treatments, sign this petition today asking the White House to implement the National Pain Strategy. The National Fibromyalgia & Chronic Pain Association (NFMCPA), with the Consumer Pain Advocacy Task Force (CPATF), recently launched a […]

BioElectronics Company Update – July 22, 2016

  • July 23rd, 2016
  • News
  • 0 Comments
  • Adam Staelin

Pending U.S. FDA Market Clearance for Over-the-Counter Sales We had a second status meeting with the FDA on Wednesday, July 20, 2016. Senior Management from the Neurology and Physical Medicine Group, 4 examiners, the Head of the Physical Medicine, and the project statistician were present. The meeting went well and the tenor was very good. […]

BioElectronics Company Update July 7, 2016

  • July 8th, 2016
  • News
  • 0 Comments
  • Adam Staelin

BioElectronics Expands Pulsed Shortwave Technology Thursday, July 7, 2016 Dr. Sree Koneru, our Director of Electroceutical Research working at the Clinical Science and Engineering Research Center, New York State University, Binghamton, New York,  has made significant advances in our understanding and development of pulsed shortwave technology. A series of experiments using a unique testing device […]

BioElectronics Company Update – June 8, 2016

  • June 9th, 2016
  • News
  • 0 Comments
  • Adam Staelin

US FDA Meeting On May 24, 2016, we met with FDA reviewer for our ActiPatch device, key management from the Physical Medicine and Neurotherapeutic Devices Branch, senior leadership from the Division of Neurological and Physical Medicine Devices, and a Regulatory Advisor, Office of Device Evaluation. BioElectronics Attendees: Richard Staelin, PhD, Chairman of Board, PhD in […]

Bioelectronics Compay Update April 7, 2016

  • April 7th, 2016
  • News
  • 0 Comments
  • Adam Staelin

BioElectronics Wins “Best OTC Marketing Campaign on a Small Budget” The OTC Bulletin, the leading global trade publication for over-the-counter healthcare products, has chosen ActiPatch® Musculoskeletal Chronic Pain Relief Therapy as the winner for the “Best OTC Marketing Campaign on a Small Budget” award. A panel of six independent over-the-counter marketing experts evaluated the seven […]

BioElectronics Drug-free Chronic Pain Therapy Observation Study Results

  • March 29th, 2016
  • News
  • 0 Comments
  • bfichter

61% Pain Reduction & Decreases Medication Use in 86% (including opioids) FREDERICK, MD, USA, March 29, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of the drug-free over-the-counter, $30.00 ActiPatch® (www.actipatch.com) Musculoskeletal Pain Therapy medical devices, announced today the completion of a 6-month ActiPatch product observation study conducted in conjunction with its ongoing market […]

BioElectronics and B. Braun Medical Ltd Apply for Prescription Payment Clearance on the UK Drug Tariff

  • February 18th, 2016
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. Feb 18, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that B. Braun has initiated the application for a listing of RecoveryRx® on the National Health Service (NHS) drug tariff (http://www.nhsbsa.nhs.uk/PrescriptionServices/4940.aspx).The UK drug tariff list establishes payment for prescription costs in the UK. “Orthopedic surgeons […]

BioElectronics Corporation Refutes SEC Order for Administrative Proceedings

  • February 8th, 2016
  • News
  • 0 Comments
  • bfichter

FREDERICK, Md., Feb. 8, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today that it is responding to a notice of an order for administrative proceedings from the Securities and Exchange Commission posted on the agency website. “Although neither the Company nor any of the respondents have been […]